Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | THRM | BY |
|---|---|---|
| Price | $30.38 | $36.57 |
| Change today | ▼ 2.00% | ▼ 2.06% |
| Market cap | $1.65B | $1.65B |
| Return, 3 months | -9.3% | -1.2% |
| Return, year to date | -11.0% | +26.8% |
| Return, 1 year | -7.1% | +34.7% |
| P/E (TTM) | 35.3 | 11.0 |
| P/B | 2.3 | 1.3 |
| P/E percentile vs own 5y | 47th | 83rd |
| Dividend yield | – | 1.20% |
| Revenue growth (YoY, latest qtr) | +11.0% | +6.6% |
| Net profit growth (YoY) | +826.6% | +33.6% |
| Gross margin | 24.0% | – |
| Operating margin | 5.2% | – |
| Net margin | 1.7% | 32.7% |
| Return on equity | 3.7% | 12.0% |
| Analyst target vs. price | +70.3% | +15.8% |
| Analyst buy share | 100% | 25% |
| RSI (14) | 32 | 38 |
| 30-day volatility | 35.1% | 14.8% |
| Max drawdown, 1 year | -30.3% | -10.5% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
